AI for retrobiosynthesis: biobulbul and diversification identifying conserved order in target signatures (DICOTS)
Ended Definitive Contract Awarded Last action
- Contract number
- HR001124C0470
- Awardee
-
RTX BBN Technologies, Inc. UEI JAXJSTJJSP74
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $1,714,190
Award facts
- Opportunity
-
- Biological Technologies Pre-Solicitation · HR001123S0045 · Posted Jun 22, 2023
- Contract value 86% obligated
-
- $1,714,190.00 Current, with exercised options
- $1,995,269.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Cambridge, MA 02138, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $360 | |
| Exercise an Option | $282,489 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,431,341 |
About this award
RTX BBN Technologies, Inc. (doing business as BBN Technologies) received a $1.995 million definitive contract award from the Defense Advanced Research Projects Agency (DARPA) on June 17, 2024, for artificial intelligence research in retrobiosynthesis under the program title "AI for Retrobiosynthesis: BioBulbul and Diversification Identifying Conserved Order in Target Signatures (DICOTS)." The contract is structured as a cost-plus-fixed-fee arrangement with no set-aside designation and carries an ultimate completion date of February 16, 2026. The work will be performed at the contractor's Cambridge, Massachusetts facility. This award emerged from a DARPA Broad Agency Announcement posted in June 2023 that solicited revolutionary research ideas in biological technologies across topic areas including biosecurity, biosafety, and biomedical applications, with proposals accepted on a rolling basis through September 2024.
BBN Technologies, a subsidiary of Raytheon Technologies Corporation, is a longstanding DARPA research partner with extensive experience in advanced technology research and development across quantum computing, artificial intelligence, cybersecurity, and autonomous systems. The company routinely executes cost-plus-fixed-fee contracts for DARPA involving academic and industry subcontractors, and maintains multiple large indefinite delivery vehicles with the agency and other defense organizations. This DICOTS program contract represents another addition to BBN Technologies' significant portfolio of DARPA research initiatives focused on emerging and transformative technologies critical to national defense and intelligence missions.
Quick answers
Who was awarded contract HR001124C0470?
HR001124C0470 was awarded to RTX BBN Technologies, Inc. by Defense Advanced Research Projects Agency (Department of Defense) on June 17, 2024.
How much is contract HR001124C0470 worth?
The government has obligated $1,714,190 on HR001124C0470. Its potential value, with all options, is $1,995,269.
Was contract HR001124C0470 competed?
The extent of competition for HR001124C0470 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award